- Advertisement -
The Therapeutic Goods Administration is waiting on more data from the US before deciding whether to approve the Pfizer or Moderna vaccines for children aged five to 11. If they are approved, the technical advisory group will then advise the government on the details of the rollout.
Vaccine…

